https://www.selleckchem.com/pr....oducts/Vandetanib.ht
in cortical cataract patients than it was in normal controls. In summary, these findings suggest a mechanism by which a point mutation in disrupts protein stability, expedites protein degradation, and decreases cell mobility. Importantly, this mutant is associated with cortical cataracts. In summary, these findings suggest a mechanism by which a point mutation in EPHA2 disrupts protein stability, expedites protein degradation, and decreases cell mobility. Importantly, this mutant is associated with cortical cataracts. Proper aqueous
Gefällt mir
Kommentar
Teilen
